Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000144888 | SCV000515511 | likely benign | not provided | 2020-08-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23414114, 23632791, 22562657, 20558321, 22056721, 22840528, 24068186, 24667784, 19120683, 30847666) |
Invitae | RCV001085300 | SCV000636994 | likely benign | Brugada syndrome | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621636 | SCV000736464 | benign | Cardiovascular phenotype | 2017-01-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Advanced Laboratory Medicine, |
RCV000852667 | SCV000995374 | likely benign | Hypertrophic cardiomyopathy | 2017-06-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000144888 | SCV004134528 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | KCNJ8: PP2, BP4, BS2 |
Prevention |
RCV003927417 | SCV004738732 | benign | KCNJ8-related disorder | 2019-05-10 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
OMIM | RCV000144888 | SCV000191890 | uncertain significance | not provided | 2014-07-01 | no assertion criteria provided | literature only |